187
Sa29 Current concepts in the management of submacular hemorrhage in AMD
Symposium of the DOG 2020 Online
Sa29 Current concepts in the management of submacular hemorrhage in AMD
Symposium of the DOG 2020 Online
INTERPLAN AG
Congress, Meeting & Event Management AG
Landsberger Straße 155
DE - 80687 München
Tel.: +49 (0)89 548 234 35
Tel.: +49 (0)89 548 234 0
Fax: +49 (0)89 548 234 43
Fax: +49 (0)89 548 234 44
Chairman
| Jost Hillenkamp, Würzburg |
| Lars-Olof Hattenbach, Ludwigshafen |
-
Basisinformation
Datum10.10.2020, 18:30 - 19:15SpracheEnglischGebühren abgebührenfreiVeranstalterDOG - Deutsche Ophthalmologische Gesellschaft e.V.
OrganisatorINTERPLAN AG
Congress, Meeting & Event Management AG
Landsberger Straße 155
DE - 80687 München
Tel.: +49 (0)89 548 234 35
Tel.: +49 (0)89 548 234 0
Fax: +49 (0)89 548 234 43
Fax: +49 (0)89 548 234 44Chairman
Jost Hillenkamp, Würzburg Lars-Olof Hattenbach, Ludwigshafen -
Programm
18:30 – 18:36
Sa29-01 - A revised classification of submacular haemorrhage using ocular imaging is helpful in clinical decision making
Referent/in: Silvia Bopp, Bremen
18:36 – 18:42 Sa29-02 - Epidemiology and risk factors of submacular hemorrhage in AMD and anti-VEGF monotherapy
Referent/in: Nicolas Feltgen, Göttingen
The epidemiological data of submacular hemorrhage are presented, additionally the spontaneous course and efficacy of anti-VEGF monotherapy.
18:42 – 18:48 Sa29-03 - Reducing risks in the management of macular hemorrhage - minimally invasive and digitally assisted surgical approaches
Referent/in: Lars-Olof Hattenbach, Ludwigshafen
18:48 – 18:54 Sa29-04 - Autologous RPE-choroid patch translocation for large submacular hemorrhages in AMD: evolution of an established surgical technique
Referent/in: Grazia Pertile, Verona, Italy
18:54 – 19:00 Sa29-05 - TIGER: a pan-European randomized clinical trial investigating treatment of submacular hemorrhage in AMD
Referent/in: Jost Hillenkamp, Würzburg
The TIGER study is a 65 centre non-commercial pan-European randomized clinical trial funded by Euretina and supported by Bayer investigating treatment of submacular hemorrhage in AMD. The aim is to study safety and efficacy of vitrectomy, sub-retinal TPA and gas for submacular haemorrhage due to wet AMD followed by intravitreal application of aflibercept compared to treatment with intravitreal aflibercept alone.
19:00 – 19:15 Sa29-06 - Diskussion
-
Gebühren
Fachärzte/-innenGebühren ab120,00 EURÄrzte/-innen in WeiterbildungGebühren ab120,00 EURStudenten/-innenGebühren abgebührenfreiThe full congress is free for students and PhD students.
-
Buchung / Anmeldung
Please contact the roganizer for further information.
-
Zertifizierung
Keine Zertifizierung beantragt